Objectives: To identify predictors of conversion to definite multiple sclerosis (MS) in patients with a cord clinically isolated syndrome.
Methods: The predictive values for conversion to MS of clinical, magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) variables in 114 patients with acute partial myelitis confirmed by a spinal cord lesion on MRI were studied. Other causes of cord syndromes were excluded.
Results: MS was diagnosed in 78 patients (86%) during 4.0 ± 1.9 years of follow-up. Some 67 of these patients had a second clinical episode. The diagnosis of isolated myelitis was maintained for 36 patients, 78% of whom (28 cases) were followed for at least 2 years, comparable to the MS patients. Age, bladder involvement, ≥2 cord lesions on MRI, ≥9 brain lesions, ≥3 periventricular lesions and intrathecal IgG synthesis predicted conversion to clinically definite MS. Multivariate logistic analysis identified three predictors of MS diagnosis: age ≤40 years, inflammatory CSF and ≥3 periventricular lesions on brain MRI.
Conclusion: Two out of three baseline factors (age, periventricular lesions and inflammatory CSF) predicted conversion to MS with better accuracy than the revised McDonald criteria for dissemination in space.
MillerDBarkhofFMontalbanX. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol2005; 4: 281–288.
2.
McDonaldWICompstonAEdanG. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol2001; 50: 121–127.
3.
PolmanCHReingoldSCEdanG. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol2005; 58: 840–846.
4.
BarkhofFFilippiMMillerDH. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain1997; 120: 2059–2069.
5.
TintoréMRoviraAMartinezM. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol2000; 21: 702–706.
6.
SwantonJKFernandoKTDaltonCM. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry2006; 77: 830–833.
Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology2002; 59: 499–505.
9.
WingerchukDMLennonVAPittockSJLucchinettiCFWeinshenkerBG. Revised diagnostic criteria for neuromyelitis optica. Neurology2006; 66: 1485–1489.
10.
de SezeJStojkovicTBreteauG. Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases. Brain2001; 124: 1509–1521.
11.
KurtzkeJF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983; 33: 1444–1452.
12.
DaltonCMBrexPAMiszkielKA. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol2002; 52: 47–53.
13.
TintoréMRoviraARíoJ. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology2003; 60: 27–30.
14.
TintoréMRoviraARioJ. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology2006; 67: 968–972.
15.
VillarLMGarcía-BarragánNSádabaMC. Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis. J Neurol Sci2008; 266: 34–37.
16.
LoCPKaoHWChenSY. Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton’s modified criteria. J Neurol Neurosurg Psychiatry2009; 80: 1107–1109.
17.
SwantonJKRoviraATintoréM. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol2007; 6: 677–686.
18.
KortewegTTintoréMUitdehaagB. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol2006; 5: 221–227.
19.
TintoréMRoviraARíoJ. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?. Neurology2008; 70: 1079–1083.
20.
BeckRWChandlerDLColeSR. Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses. Ann Neurol2002; 51: 481–490.
21.
CordonnierCde SezeJBreteauG. Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol2003; 250: 1447–1452.
22.
ConfavreuxCVukusicSAdeleineP. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain2003; 126: 770–782.
23.
de SezeJLanctinCLebrunC. Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology2005; 65: 1950–1953.
24.
BrunaJMartínez-YélamosSMartínez-YélamosA. Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler2006; 12: 169–173.
25.
SwantonJKFernandoKTDaltonCM. Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis. Mult Scler2010; 16(2): 156–165.
